Immunogenicity of a new, inactivated canine adenovirus type 2 vaccine for dogs

PURPOSE: We constructed a new canine adenovirus type 2 (CAV-2) vaccine candidate using the recently isolated Korean CAV-2 strain; we termed the vaccine APQA1701-40P and evaluated its safety and immunogenicity in dogs. MATERIALS AND METHODS: To generate the anti-CAV-2 vaccine, APQA1701 was passaged 4...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Exp Vaccine Res
Hlavní autoři: Yang, Dong-Kun, Kim, Ha-Hyun, Yoo, Jae Young, Ji, Miryeon, Han, Bok Hee, Oh, Subin, Hyun, Bang-Hun
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Vaccine Society 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7024732/
https://ncbi.nlm.nih.gov/pubmed/32095439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7774/cevr.2020.9.1.40
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky